Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
$103.54
-0.3%
$109.54
$77.56
$116.04
$25.18B0.682.25 million shs721,270 shs
McKesson Co. stock logo
MCK
McKesson
$543.05
+0.6%
$527.50
$352.34
$544.36
$71.36B0.45681,570 shs266,351 shs
ResMed Inc. stock logo
RMD
ResMed
$216.27
+17.9%
$186.31
$132.24
$243.52
$31.81B0.671.04 million shs3.00 million shs
10 Best Stocks to Own in 2024 Cover

Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
+0.27%-2.07%-7.00%-1.79%+29.13%
McKesson Co. stock logo
MCK
McKesson
+0.82%+4.07%+0.72%+11.31%+50.30%
ResMed Inc. stock logo
RMD
ResMed
-0.17%+3.28%-5.53%-3.53%-18.08%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
4.3634 of 5 stars
1.34.03.33.61.71.73.1
McKesson Co. stock logo
MCK
McKesson
4.8598 of 5 stars
2.45.03.33.03.12.52.5
ResMed Inc. stock logo
RMD
ResMed
4.584 of 5 stars
2.41.04.24.52.71.72.5

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
2.55
Moderate Buy$103.07-0.45% Downside
McKesson Co. stock logo
MCK
McKesson
2.83
Moderate Buy$533.50-1.76% Downside
ResMed Inc. stock logo
RMD
ResMed
2.70
Moderate Buy$203.30-6.00% Downside

Current Analyst Ratings

Latest CAH, MCK, and RMD Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/26/2024
ResMed Inc. stock logo
RMD
ResMed
Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$205.00 ➝ $200.00
4/26/2024
ResMed Inc. stock logo
RMD
ResMed
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetSector Perform ➝ Sector Perform$187.00 ➝ $200.00
4/26/2024
ResMed Inc. stock logo
RMD
ResMed
KeyCorp
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$227.00 ➝ $238.00
4/26/2024
ResMed Inc. stock logo
RMD
ResMed
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$224.00 ➝ $236.00
4/15/2024
McKesson Co. stock logo
MCK
McKesson
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$522.00 ➝ $548.00
4/10/2024
McKesson Co. stock logo
MCK
McKesson
Argus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$510.00 ➝ $570.00
4/1/2024
ResMed Inc. stock logo
RMD
ResMed
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$215.00 ➝ $224.00
3/27/2024
ResMed Inc. stock logo
RMD
ResMed
Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$215.00
3/6/2024
McKesson Co. stock logo
MCK
McKesson
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$575.00 ➝ $620.00
2/26/2024
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
Leerink Partnrs
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform
2/26/2024
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
SVB Leerink
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOutperform$125.00
(Data available from 4/26/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
$205.01B0.12$8.69 per share11.92($11.20) per share-9.24
McKesson Co. stock logo
MCK
McKesson
$276.71B0.26$32.67 per share16.62($10.99) per share-49.41
ResMed Inc. stock logo
RMD
ResMed
$4.22B7.53$9.19 per share23.54$28.11 per share7.69

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
$261M$2.5440.7613.011.000.30%-57.44%3.89%5/2/2024 (Confirmed)
McKesson Co. stock logo
MCK
McKesson
$3.56B$22.0724.6117.481.420.99%-262.63%5.96%5/7/2024 (Confirmed)
ResMed Inc. stock logo
RMD
ResMed
$897.56M$6.0535.7526.122.2519.77%23.86%14.78%8/1/2024 (Estimated)

Latest CAH, MCK, and RMD Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/7/2024N/A
McKesson Co. stock logo
MCK
McKesson
$6.39N/A-$6.39N/AN/AN/A  
5/2/2024N/A
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
$1.96N/A-$1.96N/AN/AN/A  
4/25/2024Q3 24
ResMed Inc. stock logo
RMD
ResMed
$1.91$2.13+$0.22$2.22$1.17 billion$1.20 billion    
2/7/2024Q3 2024
McKesson Co. stock logo
MCK
McKesson
$7.05$7.74+$0.69$11.06$77.93 billion$80.90 billion    
2/1/2024Q2 2024
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
$1.56$1.82+$0.26$2.21$57.02 billion$57.45 billion    

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
$2.001.93%+1.00%78.74%27 Years
McKesson Co. stock logo
MCK
McKesson
$2.480.46%+11.80%11.24%16 Years
ResMed Inc. stock logo
RMD
ResMed
$1.920.89%+5.66%31.74%12 Years

Latest CAH, MCK, and RMD Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
4/24/2024
McKesson Co. stock logo
MCK
McKesson
quarterly$0.620.47%6/3/20246/3/20247/1/2024
2/6/2024
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
quarterly$0.50061.92%3/28/20244/1/20244/15/2024
2/1/2024
McKesson Co. stock logo
MCK
McKesson
quarterly$0.620.5%2/29/20243/1/20244/1/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
N/A
0.98
0.50
McKesson Co. stock logo
MCK
McKesson
N/A
0.92
0.50
ResMed Inc. stock logo
RMD
ResMed
0.27
3.11
1.89

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
87.17%
McKesson Co. stock logo
MCK
McKesson
85.07%
ResMed Inc. stock logo
RMD
ResMed
54.98%

Insider Ownership

CompanyInsider Ownership
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
0.15%
McKesson Co. stock logo
MCK
McKesson
0.21%
ResMed Inc. stock logo
RMD
ResMed
1.21%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
48,000243.23 million242.87 millionOptionable
McKesson Co. stock logo
MCK
McKesson
51,000131.41 million131.13 millionOptionable
ResMed Inc. stock logo
RMD
ResMed
10,140147.09 million145.31 millionOptionable

CAH, MCK, and RMD Headlines

SourceHeadline
ResMed (NYSE:RMD) Given New $200.00 Price Target at OppenheimerResMed (NYSE:RMD) Given New $200.00 Price Target at Oppenheimer
marketbeat.com - April 26 at 2:44 PM
ResMed Inc. (NYSE:RMD) Stock Position Decreased by Pittenger & Anderson Inc.ResMed Inc. (NYSE:RMD) Stock Position Decreased by Pittenger & Anderson Inc.
marketbeat.com - April 26 at 2:28 PM
ResMed (NYSE:RMD) Price Target Raised to $200.00 at Royal Bank of CanadaResMed (NYSE:RMD) Price Target Raised to $200.00 at Royal Bank of Canada
marketbeat.com - April 26 at 12:41 PM
Why ResMed Stock Is Soaring TodayWhy ResMed Stock Is Soaring Today
fool.com - April 26 at 12:08 PM
ResMed (NYSE:RMD) Shares Gap Up  After Better-Than-Expected EarningsResMed (NYSE:RMD) Shares Gap Up After Better-Than-Expected Earnings
marketbeat.com - April 26 at 10:55 AM
Breaking Down the Key Takeaways from Resmed Inc. (RMD) Quarterly ReportBreaking Down the Key Takeaways from Resmed Inc. (RMD) Quarterly Report
marketbeat.com - April 26 at 10:11 AM
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Integer Holdings (ITGR), Resmed (RMD) and PTC Therapeutics (PTCT)Analysts’ Opinions Are Mixed on These Healthcare Stocks: Integer Holdings (ITGR), Resmed (RMD) and PTC Therapeutics (PTCT)
markets.businessinsider.com - April 26 at 10:09 AM
Australian Stocks: ResMed (RMD) Shares Surge on Robust Q3 ResultsAustralian Stocks: ResMed (RMD) Shares Surge on Robust Q3 Results
markets.businessinsider.com - April 26 at 10:09 AM
ResMed Analysts Boost Their Forecasts After Better-Than-Expected EarningsResMed Analysts Boost Their Forecasts After Better-Than-Expected Earnings
benzinga.com - April 26 at 10:09 AM
ResMed (RMD) Q3 Earnings Beat Estimates, Margins ExpandResMed (RMD) Q3 Earnings Beat Estimates, Margins Expand
zacks.com - April 26 at 9:41 AM
ResMed Stock Soars After Strong Earnings. Wall Street Thinks It Can Do Even Better.ResMed Stock Soars After Strong Earnings. Wall Street Thinks It Can Do Even Better.
barrons.com - April 26 at 8:33 AM
ASX 200 thumped as nagging inflation dashes 2024 rate cut hopes, gold & copper only places to hideASX 200 thumped as nagging inflation dashes 2024 rate cut hopes, gold & copper only places to hide
livewiremarkets.com - April 26 at 5:08 AM
ResMed Inc (RMD) Q3 2024 Earnings Call Transcript Highlights: Strong Financial Performance and ...ResMed Inc (RMD) Q3 2024 Earnings Call Transcript Highlights: Strong Financial Performance and ...
finance.yahoo.com - April 26 at 5:08 AM
ResMed share price jumps 10% on strong quarterly updateResMed share price jumps 10% on strong quarterly update
msn.com - April 26 at 12:07 AM
ResMed Inc. 2024 Q3 - Results - Earnings Call PresentationResMed Inc. 2024 Q3 - Results - Earnings Call Presentation
seekingalpha.com - April 25 at 9:38 PM
RMD Stock Earnings: ResMed Beats EPS, Beats Revenue for Q3 2024RMD Stock Earnings: ResMed Beats EPS, Beats Revenue for Q3 2024
investorplace.com - April 25 at 8:11 PM
Compared to Estimates, ResMed (RMD) Q3 Earnings: A Look at Key MetricsCompared to Estimates, ResMed (RMD) Q3 Earnings: A Look at Key Metrics
zacks.com - April 25 at 7:31 PM
ResMed: Fiscal Q3 Earnings SnapshotResMed: Fiscal Q3 Earnings Snapshot
timesunion.com - April 25 at 7:07 PM
Resmed Inc Q3 Profit Increases, beats estimatesResmed Inc Q3 Profit Increases, beats estimates
markets.businessinsider.com - April 25 at 7:07 PM
ResMed sees increased sleep device demand, stock rises on Q3 beatsResMed sees increased sleep device demand, stock rises on Q3 beats
massdevice.com - April 25 at 7:07 PM
ResMed Inc (RMD) Q3 Fiscal 2024 Earnings: Surpasses Analyst Expectations with Strong GrowthResMed Inc (RMD) Q3 Fiscal 2024 Earnings: Surpasses Analyst Expectations with Strong Growth
finance.yahoo.com - April 25 at 7:07 PM
ResMed (NYSE:RMD) Releases Quarterly  Earnings Results, Beats Estimates By $0.22 EPSResMed (NYSE:RMD) Releases Quarterly Earnings Results, Beats Estimates By $0.22 EPS
marketbeat.com - April 25 at 7:01 PM
ResMed (RMD) Q3 Earnings and Revenues Surpass EstimatesResMed (RMD) Q3 Earnings and Revenues Surpass Estimates
zacks.com - April 25 at 6:26 PM
ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2024ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2024
globenewswire.com - April 25 at 4:05 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Cardinal Health logo

Cardinal Health

NYSE:CAH
Cardinal Health, Inc. operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. The company operates in two segments, Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The segment also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; operates nuclear pharmacies and radiopharmaceutical manufacturing facilities; repackages generic pharmaceuticals and over-the-counter healthcare products; and provides pharmacy management services to hospitals. The Medical segment manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compressions; incontinences; nutritional delivery products; wound care products; single-use surgical drapes, gowns, and apparels; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. The segment also distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile, and non-sterile procedure kits. The company was incorporated in 1979 and is headquartered in Dublin, Ohio.
McKesson logo

McKesson

NYSE:MCK
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The RxTS segment serves biopharma and life sciences partners and patients to address medication challenges for patients by working across healthcare; connects patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies to deliver innovative solutions to help people get the medicine needed to live healthier lives; and provides prescription price transparency, benefit insight, dispensing support, third-party logistics, and wholesale distribution support services. The Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, hospital reference labs, and home health care agencies. The International segment offers distribution and services to wholesale, institutional, and retail customers in Europe and Canada. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.
ResMed logo

ResMed

NYSE:RMD
ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. It operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including technologies to be applied in medical and consumer products, ventilation devices, diagnostic products, mask systems for use in the hospital and home, headgear and other accessories, dental devices, and cloud-based software informatics solutions to manage patient outcomes, as well as provides customer and business processes. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME) to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies; and MEDIFOX DAN's software solutions. The company markets its products to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force. The company was founded in 1989 and is headquartered in San Diego, California.